NEW YORK, June 25, 2019 /PRNewswire/ -- WeissLaw
LLP is investigating possible breaches of fiduciary duty
and other violations of law by the Board of Directors of Allergan
Plc ("Allergan" or the "Company") (NYSE: AGN) in connection with
the proposed acquisition of the Company by AbbVie Inc. (NYSE:
ABBV). Under the terms of the agreement, Allergan
shareholders will receive $120.30 in
cash and 0.8660 shares of ABBV for each share of AGN share they
own, representing consideration of $181.32 based on ABBV's June 25 opening price.
If you own AGN shares and wish to discuss this
investigation or have any questions concerning this notice or your
rights or interests, please contact:
Joshua Rubin,
Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888)
593-4771
stockinfo@weisslawllp.com
Visit our
website
http://www.weisslawllp.com/allergan-plc/
Or follow us on Twitter @MarketsAlert
WeissLaw is investigating whether Allergan's Board acted to
maximize shareholder value prior to entering into the acquisition
agreement. Notably, at least one analyst set a target price
of $255.00, or approximately
$74 above the per share
consideration.
WeissLaw is investigating whether Allergan' Board conducted a
fair process in agreeing to the proposed acquisition, whether the
proposed acquisition undervalues the Company, and whether all
material information related to the proposed acquisition is fully
and fairly disclosed.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for
defrauded clients and obtained important corporate governance
relief in many of these cases. If you have information or
would like legal advice concerning possible corporate wrongdoing
(including insider trading, waste of corporate assets, accounting
fraud, or materially misleading information), consumer fraud
(including false advertising, defective products, or other
deceptive business practices), or anti-trust violations, please
email us at stockinfo@weisslawllp.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-allergan-plc-300874815.html
SOURCE WeissLaw LLP